Therapeutics for Alzheimer's Disease Based on the Metal Hypothesis
Top Cited Papers
Open Access
- 1 July 2008
- journal article
- review article
- Published by Elsevier in Neurotherapeutics
- Vol. 5 (3), 421-432
- https://doi.org/10.1016/j.nurt.2008.05.001
Abstract
No abstract availableKeywords
This publication has 130 references indexed in Scilit:
- Altered ATP7A expression and other compensatory responses in a murine model of Menkes diseaseNeurobiology of Disease, 2007
- Engineering metal ion coordination to regulate amyloid fibril assembly and toxicityProceedings of the National Academy of Sciences, 2007
- Mitochondrial Oxidative Stress Causes Hyperphosphorylation of TauPLOS ONE, 2007
- Overexpression of CCS in G93A-SOD1 mice leads to accelerated neurological deficits with severe mitochondrial pathologyProceedings of the National Academy of Sciences, 2007
- Membrane-mediated Amyloidogenesis and the Promotion of Oxidative Lipid Damage by Amyloid β ProteinsJournal of Biological Chemistry, 2007
- ATP7A (Menkes protein) functions in axonal targeting and synaptogenesisMolecular and Cellular Neuroscience, 2007
- Therapeutic targets and potential of the novel brain‐ permeable multifunctional iron chelator–monoamine oxidase inhibitor drug, M‐30, for the treatment of Alzheimer's disease1Journal of Neurochemistry, 2006
- Role of the Menkes copper-transporting ATPase in NMDA receptor-mediated neuronal toxicityProceedings of the National Academy of Sciences, 2006
- Iron, brain ageing and neurodegenerative disordersNature Reviews Neuroscience, 2004
- Oxidative damage in Alzheimer'sNature, 1996